Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
5.50
-0.49 (-8.18%)
Aug 18, 2026, 4:00 PM EST
Silence Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -59.95 | -88.61 | -45.31 | -54.23 | -50.33 | -53.36 |
Depreciation & Amortization | 0.48 | 0.56 | 0.59 | 0.62 | 0.6 | 0.58 |
Stock-Based Compensation | 6.2 | 8.07 | 16.31 | 16.27 | 12.69 | 11.69 |
Other Operating Activities | -3.29 | 7.55 | -6.21 | 3.12 | -0.6 | -2.29 |
Change in Accounts Receivable | 0.09 | 1.02 | -0.9 | 0.39 | -0.72 | 37.21 |
Change in Accounts Payable | -1.44 | -4.08 | 0.5 | -0.47 | 2.02 | 3.26 |
Change in Unearned Revenue | -0.52 | -0.33 | -28.79 | -10.32 | -5.44 | 11.33 |
Change in Other Net Operating Assets | 16.16 | 13.55 | -3.83 | -4.84 | -15.26 | 0.8 |
Operating Cash Flow | -42.26 | -62.27 | -67.64 | -49.46 | -57.04 | 9.22 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0 | -0.06 | -0.21 | -0.06 | -0.17 | -1.78 |
Sale (Purchase) of Intangibles | - | - | - | - | -0.37 | -0.03 |
Investment in Securities | 72.89 | -47.94 | -21.76 | 19.35 | -19.95 | 13.54 |
Other Investing Activities | - | - | - | - | - | 0.01 |
Investing Cash Flow | 72.89 | -47.99 | -21.97 | 19.29 | -20.5 | 11.75 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | - | - | -0.29 |
Net Debt Issued (Repaid) | - | - | - | - | - | -0.29 |
Issuance of Common Stock | 0 | 0.02 | 142.09 | 31.94 | 52.58 | 41.87 |
Financing Cash Flow | 0 | 0.02 | 142.09 | 31.94 | 52.58 | 41.58 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0.32 | 0.2 | 0.06 | 0.75 | -8.12 | -0.14 |
Net Cash Flow | 30.32 | -110.05 | 52.54 | 2.52 | -33.08 | 62.41 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -42.27 | -62.33 | -67.85 | -49.52 | -57.22 | 7.44 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -6872.52% | -11149.55% | -156.85% | -156.49% | -264.22% | 44.26% |
Free Cash Flow Per Share | -0.90 | -1.32 | -1.47 | -1.33 | -1.78 | 0.25 |
Levered Free Cash Flow | -23.57 | -39.55 | -25.37 | -23.31 | -26.84 | -6.72 |
Unlevered Free Cash Flow | -23.57 | -39.55 | -25.37 | -23.31 | -26.84 | -6.71 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 0.3 | 0.64 | 0.43 | 0.8 | - | - |
Change in Working Capital | 14.29 | 10.16 | -33.02 | -15.24 | -19.4 | 52.6 |